Effect of plasma-derived or recombinant factor VIII on inhibitor development. A systematic review

被引：0
|
作者：
Iorio, A.
Halimeh, S.
Bidlingmaier, C.
Ettingshausen, C. E.
Gringeri, A.
Holzhauer, S.
Knoefler, R.
Kreuz, W.
Kurnik, K.
Manner, D.
Santagostino, E.
Mannucci, P. M.
Nowak-Goettl, U.
机构：
来源：
HAEMOPHILIA | 2010年 / 16卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：410 / 410
页数：1
相关论文
共 50 条
  • [41] A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease
    Rugeri, Lucia
    Thomas, Will
    Schirner, Kathrin
    Heyder, Lisa
    Auerswald, Guenter
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (09) : 828 - 841
  • [42] Plasma derived (PD) and recombinant (R) factor VIII (FVIII) concentrates induce a different rate of inhibitor development in hemophilia A patients. a systematic review of the literature
    Iorio, A.
    Marcucci, M.
    Marchesini, E.
    Mannucci, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 115 - 115
  • [43] Plasma-derived factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A: report of the FranceCoag Network
    Goudemand, J.
    Rothschild, C.
    d'Oiron, R.
    Demiguel, V
    Dalibard, V
    Micheau, M.
    Lutz, P.
    Gruel, Y.
    Vinciguerra, C.
    Chambost, H.
    Calvez, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 148 - 148
  • [44] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 46 - 47
  • [45] INCIDENCE OF FACTOR-VIII INHIBITOR DEVELOPMENT IN HEMOPHILIA-A PATIENTS TREATED WITH LESS PURE PLASMA-DERIVED CONCENTRATES
    DEBIASI, R
    ROCINO, A
    PAPA, ML
    SALERNO, E
    MASTRULLO, L
    DEBLASI, D
    THROMBOSIS AND HAEMOSTASIS, 1994, 71 (05) : 544 - 547
  • [46] Viral safety of plasma-derived factor VIII and IX concentrates
    Ludlam, CA
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S19 - S23
  • [47] Cellular Stress Induced by Plasma-Derived Factor VIII Products
    Brodde, Martin
    Mueller, Anja
    Kehrel, Beate
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (02) : 140 - 144
  • [48] VIRAL SAFETY ISSUES - PLASMA-DERIVED FACTOR-VIII
    BERNTORP, E
    ANNALS OF HEMATOLOGY, 1994, 68 : S35 - S36
  • [49] Pharmacokinetics (PK) of recombinant and plasma-derived factor VIII (FVIII) products in pediatric patients with severe hemophilia A
    Steele, M.
    Chan, A.
    Nagel, K.
    HAEMOPHILIA, 2012, 18 : 35 - 35
  • [50] Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice
    Qadura, Mohammad
    Waters, Braden
    Burnett, Erin
    Chegeni, Rouzbeh
    Bradshaw, Scott
    Hough, Christine
    Othman, Maha
    Lillicrap, David
    BLOOD, 2009, 114 (04) : 871 - 880
12345